{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T03:12:31Z","timestamp":1793761951796,"version":"4.6.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T00:00:00Z","timestamp":1667865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T00:00:00Z","timestamp":1667865600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"DOI":"10.1007\/s00223-022-01039-y","type":"journal-article","created":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T18:03:33Z","timestamp":1667930613000},"page":"289-296","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Diagnostic Approach to Patients with Low Serum Alkaline Phosphatase"],"prefix":"10.1007","volume":"112","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0691-8755","authenticated-orcid":false,"given":"Jose A.","family":"Riancho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,8]]},"reference":[{"key":"1039_CR1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.bone.2017.02.011","volume":"102","author":"MP Whyte","year":"2017","unstructured":"Whyte MP (2017) Hypophosphatasia: an overview for 2017. Bone 102:15\u201325. https:\/\/doi.org\/10.1016\/j.bone.2017.02.011","journal-title":"Bone"},{"key":"1039_CR2","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/NRENDO.2016.14","volume":"12","author":"MP Whyte","year":"2016","unstructured":"Whyte MP (2016) Hypophosphatasia\u2014aetiology, nosology, pathogenesis, diagnosis and treatment. Nat Rev Endocrinol 12:233\u2013246. https:\/\/doi.org\/10.1038\/NRENDO.2016.14","journal-title":"Nat Rev Endocrinol"},{"key":"1039_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/BIOM11111564","author":"S Sekaran","year":"2021","unstructured":"Sekaran S, Selvaraj V, Thangavelu L (2021) The physiological and pathological role of tissue nonspecific alkaline phosphatase beyond mineralization. Biomolecules. https:\/\/doi.org\/10.3390\/BIOM11111564","journal-title":"Biomolecules"},{"key":"1039_CR4","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/J.JOB.2019.07.003","volume":"61","author":"K Komaru","year":"2019","unstructured":"Komaru K, Ishida-Okumura Y, Numa-Kinjoh N et al (2019) Molecular and cellular basis of hypophosphatasia. J oral Biosci 61:141\u2013148. https:\/\/doi.org\/10.1016\/J.JOB.2019.07.003","journal-title":"J oral Biosci"},{"key":"1039_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/S13023-021-02084-W","author":"T Schmidt","year":"2021","unstructured":"Schmidt T, Schmidt C, Amling M et al (2021) Prevalence of low alkaline phosphatase activity in laboratory assessment: is hypophosphatasia an underdiagnosed disease? Orphanet J Rare Dis. https:\/\/doi.org\/10.1186\/S13023-021-02084-W","journal-title":"Orphanet J Rare Dis"},{"key":"1039_CR6","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1007\/S00198-015-3346-0","volume":"27","author":"E Maman","year":"2016","unstructured":"Maman E, Borderie D, Roux C, Briot K (2016) Absence of recognition of low alkaline phosphatase level in a tertiary care hospital. Osteoporos Int 27:1251\u20131254. https:\/\/doi.org\/10.1007\/S00198-015-3346-0","journal-title":"Osteoporos Int"},{"key":"1039_CR7","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1002\/JBMR.2110","volume":"29","author":"N Gua\u00f1abens","year":"2014","unstructured":"Gua\u00f1abens N, Mumm S, M\u00f6ller I et al (2014) Calcific periarthritis as the only clinical manifestation of hypophosphatasia in middle-aged sisters. J Bone Miner Res 29:929\u2013934. https:\/\/doi.org\/10.1002\/JBMR.2110","journal-title":"J Bone Miner Res"},{"key":"1039_CR8","first-page":"4244","volume":"7","author":"Z Wang","year":"2014","unstructured":"Wang Z, Guo H, Wang Y et al (2014) Interfering effect of bilirubin on the determination of alkaline phosphatase. Int J Clin Exp Med 7:4244","journal-title":"Int J Clin Exp Med"},{"key":"1039_CR9","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s00198-013-2447-x","volume":"25","author":"FE McKiernan","year":"2014","unstructured":"McKiernan FE, Shrestha LK, Berg RL, Fuehrer J (2014) Acute hypophosphatasemia. Osteoporos Int 25:519\u2013523","journal-title":"Osteoporos Int"},{"key":"1039_CR10","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0169-6009(08)80013-X","volume":"21","author":"J Napal","year":"1993","unstructured":"Napal J, Amado JAA, Riancho JAA et al (1993) Stress decreases the serum level of osteocalcin. Bone Miner 21:113\u2013118. https:\/\/doi.org\/10.1016\/S0169-6009(08)80013-X","journal-title":"Bone Miner"},{"key":"1039_CR11","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1056\/NEJM196409102711104","volume":"271","author":"CKV van Dommelen","year":"1964","unstructured":"van Dommelen CKV, Klaassen CHL (1964) Cyanocobalamin-dependent depression of the serum alkaline phosphatase level in patients with pernicious anemia. N Engl J Med 271:541\u2013544. https:\/\/doi.org\/10.1056\/NEJM196409102711104","journal-title":"N Engl J Med"},{"key":"1039_CR12","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1016\/S0026-0495(96)90171-7","volume":"45","author":"GS Kim","year":"1996","unstructured":"Kim GS, Kim CH, Park JY et al (1996) Effects of vitamin B12 on cell proliferation and cellular alkaline phosphatase activity in human bone marrow stromal osteoprogenitor cells and UMR106 osteoblastic cells. Metabolism 45:1443\u20131446. https:\/\/doi.org\/10.1016\/S0026-0495(96)90171-7","journal-title":"Metabolism"},{"key":"1039_CR13","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1002\/HEP.1840060509","volume":"6","author":"WA Shaver","year":"1986","unstructured":"Shaver WA, Bhatt H, Combes B (1986) Low serum alkaline phosphatase activity in Wilson\u2019s disease. Hepatology 6:859\u2013863. https:\/\/doi.org\/10.1002\/HEP.1840060509","journal-title":"Hepatology"},{"key":"1039_CR14","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/LIV.14263","volume":"40","author":"\u015e G\u00fcng\u00f6r","year":"2020","unstructured":"G\u00fcng\u00f6r \u015e, Selimo\u011flu MA, Ba\u011f HGG, Varol F (2020) Is it possible to diagnose fulminant Wilson\u2019s disease with simple laboratory tests? Liver Int 40:155\u2013162. https:\/\/doi.org\/10.1111\/LIV.14263","journal-title":"Liver Int"},{"key":"1039_CR15","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/J.JBSPIN.2010.01.013","volume":"77","author":"VE Gibbon","year":"2010","unstructured":"Gibbon VE, Harington JS, Penny CB, Fredlund V (2010) Mseleni joint disease: a potential model of epigenetic chondrodysplasia. Jt bone spine 77:399\u2013404. https:\/\/doi.org\/10.1016\/J.JBSPIN.2010.01.013","journal-title":"Jt bone spine"},{"key":"1039_CR16","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/J.METABOL.2017.08.013","volume":"82","author":"E Mornet","year":"2018","unstructured":"Mornet E (2018) Hypophosphatasia. Metabolism 82:142\u2013155. https:\/\/doi.org\/10.1016\/J.METABOL.2017.08.013","journal-title":"Metabolism"},{"key":"1039_CR17","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ejim.2015.12.019","volume":"29","author":"L Riancho-Zarrabeitia","year":"2016","unstructured":"Riancho-Zarrabeitia L, Garc\u00eda-Unzueta M, Tenorio JA et al (2016) Clinical, biochemical and genetic spectrum of low alkaline phosphatase levels in adults. Eur J Intern Med 29:40\u201345. https:\/\/doi.org\/10.1016\/j.ejim.2015.12.019","journal-title":"Eur J Intern Med"},{"key":"1039_CR18","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1007\/s00198-018-4571-0","volume":"29","author":"L L\u00f3pez-Delgado","year":"2018","unstructured":"L\u00f3pez-Delgado L, Riancho-Zarrabeitia L, Garc\u00eda-Unzueta MT et al (2018) Abnormal bone turnover in individuals with low serum alkaline phosphatase. Osteoporos Int 29:2147\u20132150. https:\/\/doi.org\/10.1007\/s00198-018-4571-0","journal-title":"Osteoporos Int"},{"key":"1039_CR19","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.bone.2013.01.024","volume":"54","author":"KE Berkseth","year":"2013","unstructured":"Berkseth KE, Tebben PJ, Drake MT et al (2013) Clinical spectrum of hypophosphatasia diagnosed in adults. Bone 54:21\u201327","journal-title":"Bone"},{"key":"1039_CR20","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1007\/S00198-017-4087-Z","volume":"28","author":"T Schmidt","year":"2017","unstructured":"Schmidt T, Mussawy H, Rolvien T et al (2017) Clinical, radiographic and biochemical characteristics of adult hypophosphatasia. Osteoporos Int 28:2653\u20132662. https:\/\/doi.org\/10.1007\/S00198-017-4087-Z","journal-title":"Osteoporos Int"},{"key":"1039_CR21","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1002\/JBMR.3928","volume":"35","author":"N Alonso","year":"2020","unstructured":"Alonso N, Larraz-Prieto B, Berg K et al (2020) Loss-of-function mutations in the ALPL gene presenting with adult onset osteoporosis and low serum concentrations of total alkaline phosphatase. J Bone Miner Res 35:657\u2013661. https:\/\/doi.org\/10.1002\/JBMR.3928","journal-title":"J Bone Miner Res"},{"key":"1039_CR22","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1002\/jbmr.253","volume":"25","author":"E Shane","year":"2010","unstructured":"Shane E, Burr D, Ebeling PR et al (2010) Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the american society for bone and mineral research. J Bone Miner Res 25:2267\u20132294. https:\/\/doi.org\/10.1002\/jbmr.253","journal-title":"J Bone Miner Res"},{"key":"1039_CR23","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1002\/jbmr.1565","volume":"27","author":"RAL Sutton","year":"2012","unstructured":"Sutton RAL, Mumm S, Coburn SP et al (2012) \u201cAtypical femoral fractures\u201d during bisphosphonate exposure in adult hypophosphatasia. J Bone Miner Res 27:987\u2013994. https:\/\/doi.org\/10.1002\/jbmr.1565","journal-title":"J Bone Miner Res"},{"key":"1039_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/JBM4.10223","author":"K Rassie","year":"2019","unstructured":"Rassie K, Dray M, Michigami T, Cundy T (2019) Bisphosphonate use and fractures in adults with hypophosphatasia. JBMR plus. https:\/\/doi.org\/10.1002\/JBM4.10223","journal-title":"JBMR plus"},{"key":"1039_CR25","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/BF01800216","volume":"13","author":"BN Chodirker","year":"1990","unstructured":"Chodirker BN, Coburn SP, Seargeant LE et al (1990) Increased plasma pyridoxal-5\u2032-phosphate levels before and after pyridoxine loading in carriers of perinatal\/infantile hypophosphatasia. J Inherit Metab Dis 13:891\u2013896. https:\/\/doi.org\/10.1007\/BF01800216","journal-title":"J Inherit Metab Dis"},{"key":"1039_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2021.116007","author":"MP Whyte","year":"2021","unstructured":"Whyte MP, May JD, McAlister WH et al (2021) Vitamin B6 deficiency with normal plasma levels of pyridoxal 5\u2032-phosphate in perinatal hypophosphatasia. Bone. https:\/\/doi.org\/10.1016\/j.bone.2021.116007","journal-title":"Bone"},{"key":"1039_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2021.116204","author":"MP Whyte","year":"2022","unstructured":"Whyte MP, Zhang F, Wenkert D et al (2022) Hypophosphatasia: vitamin B6 status of affected children and adults. Bone. https:\/\/doi.org\/10.1016\/j.bone.2021.116204","journal-title":"Bone"},{"key":"1039_CR28","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1002\/HUMU.24010","volume":"41","author":"G del Angel","year":"2020","unstructured":"del Angel G, Reynders J, Negron C et al (2020) Large-scale in vitro functional testing and novel variant scoring via protein modeling provide insights into alkaline phosphatase activity in hypophosphatasia. Hum Mutat 41:1250\u20131262. https:\/\/doi.org\/10.1002\/HUMU.24010","journal-title":"Hum Mutat"},{"key":"1039_CR29","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1007\/S00198-020-05345-9","volume":"31","author":"ML Bianchi","year":"2020","unstructured":"Bianchi ML, Bishop NJ, Gua\u00f1abens N et al (2020) Hypophosphatasia in adolescents and adults: overview of diagnosis and treatment. Osteoporos Int 31:1445\u20131460. https:\/\/doi.org\/10.1007\/S00198-020-05345-9","journal-title":"Osteoporos Int"},{"key":"1039_CR30","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/S40618-021-01625-1","volume":"45","author":"V Guarnieri","year":"2022","unstructured":"Guarnieri V, Sileri F, Indirli R et al (2022) Clinical, biochemical and genetic findings in adult patients with chronic hypophosphatasemia. J Endocrinol Invest 45:125\u2013137. https:\/\/doi.org\/10.1007\/S40618-021-01625-1","journal-title":"J Endocrinol Invest"},{"key":"1039_CR31","doi-asserted-by":"publisher","first-page":"965476","DOI":"10.3389\/fendo.2022.965476","volume":"13","author":"M Santurtun","year":"2022","unstructured":"Santurtun M, Mediavilla-Martinez E, Vega AI et al (2022) Pain and health-related quality of life in patients with hypophosphatasemia with and without ALPL gene mutations. Front Endocrinol (Lausanne) 13:965476. https:\/\/doi.org\/10.3389\/fendo.2022.965476","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1039_CR32","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1007\/S00198-021-05893-8","volume":"32","author":"L Masi","year":"2021","unstructured":"Masi L, Marini F, Franceschelli F et al (2021) Polymorphic variants of alkaline phosphatase gene correlate with clinical signs of adult hypophosphatasia? Osteoporos Int 32:2461\u20132472. https:\/\/doi.org\/10.1007\/S00198-021-05893-8","journal-title":"Osteoporos Int"},{"key":"1039_CR33","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.bone.2011.06.006","volume":"49","author":"J Delgado-Calle","year":"2011","unstructured":"Delgado-Calle J, Sanudo C, Sanchez-Verde L et al (2011) Epigenetic regulation of alkaline phosphatase in human cells of the osteoblastic lineage. Bone 49:830\u2013838","journal-title":"Bone"},{"key":"1039_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-022-02253-5","author":"C Tornero","year":"2022","unstructured":"Tornero C, Navarro-Comp\u00e1n V, Bu\u00f1o A et al (2022) Biochemical algorithm to identify individuals with ALPL variants among subjects with persistent hypophosphatasaemia. Orphanet J Rare Dis. https:\/\/doi.org\/10.1186\/s13023-022-02253-5","journal-title":"Orphanet J Rare Dis"},{"key":"1039_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/S13023-020-1315-Y","author":"C Tornero","year":"2020","unstructured":"Tornero C, Navarro-Comp\u00e1n V, Tenorio JA et al (2020) Can we identify individuals with an ALPL variant in adults with persistent hypophosphatasaemia? Orphanet J Rare Dis. https:\/\/doi.org\/10.1186\/S13023-020-1315-Y","journal-title":"Orphanet J Rare Dis"},{"key":"1039_CR36","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/S41413-018-0029-4","volume":"6","author":"W Liu","year":"2018","unstructured":"Liu W, Zhang L, Xuan K et al (2018) Alpl prevents bone ageing sensitivity by specifically regulating senescence and differentiation in mesenchymal stem cells. Bone Res 6:27. https:\/\/doi.org\/10.1038\/S41413-018-0029-4","journal-title":"Bone Res"},{"key":"1039_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/J.YMGMR.2020.100661","author":"E Huggins","year":"2020","unstructured":"Huggins E, Ong R, Rockman-Greenberg C et al (2020) Multigenerational case examples of hypophosphatasia: challenges in genetic counseling and disease management. Mol Genet Metab reports. https:\/\/doi.org\/10.1016\/J.YMGMR.2020.100661","journal-title":"Mol Genet Metab reports"},{"key":"1039_CR38","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1038\/EJHG.2014.10","volume":"22","author":"C Hofmann","year":"2014","unstructured":"Hofmann C, Girschick H, Mornet E et al (2014) Unexpected high intrafamilial phenotypic variability observed in hypophosphatasia. Eur J Hum Genet 22:1160\u20131164. https:\/\/doi.org\/10.1038\/EJHG.2014.10","journal-title":"Eur J Hum Genet"},{"key":"1039_CR39","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1056\/nejmoa1916525","volume":"383","author":"DM Black","year":"2020","unstructured":"Black DM, Geiger EJ, Eastell R et al (2020) Atypical femur fracture risk versus fragility fracture prevention with bisphosphonates. N Engl J Med 383:743\u2013753. https:\/\/doi.org\/10.1056\/nejmoa1916525","journal-title":"N Engl J Med"},{"key":"1039_CR40","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1056\/NEJMOA1106173","volume":"366","author":"MP Whyte","year":"2012","unstructured":"Whyte MP, Greenberg CR, Salman NJ et al (2012) Enzyme-replacement therapy in life-threatening hypophosphatasia. N Engl J Med 366:904\u2013913. https:\/\/doi.org\/10.1056\/NEJMOA1106173","journal-title":"N Engl J Med"},{"key":"1039_CR41","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S2213-8587(18)30307-3","volume":"7","author":"MP Whyte","year":"2019","unstructured":"Whyte MP, Simmons JH, Moseley S et al (2019) Asfotase alfa for infants and young children with hypophosphatasia: 7 year outcomes of a single-arm, open-label, phase 2 extension trial. Lancet Diabetes Endocrinol 7:93\u2013105. https:\/\/doi.org\/10.1016\/S2213-8587(18)30307-3","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1039_CR42","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/J.BONE.2018.12.011","volume":"121","author":"PS Kishnani","year":"2019","unstructured":"Kishnani PS, Rockman-Greenberg C, Rauch F et al (2019) Five-year efficacy and safety of asfotase alfa therapy for adults and adolescents with hypophosphatasia. Bone 121:149\u2013162. https:\/\/doi.org\/10.1016\/J.BONE.2018.12.011","journal-title":"Bone"},{"key":"1039_CR43","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1007\/S00198-019-04921-Y","volume":"30","author":"AA Khan","year":"2019","unstructured":"Khan AA, Josse R, Kannu P et al (2019) Hypophosphatasia: Canadian update on diagnosis and management. Osteoporos Int 30:1713\u20131722. https:\/\/doi.org\/10.1007\/S00198-019-04921-Y","journal-title":"Osteoporos Int"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-022-01039-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00223-022-01039-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-022-01039-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,25]],"date-time":"2023-02-25T16:02:54Z","timestamp":1677340974000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00223-022-01039-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,8]]},"references-count":43,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["1039"],"URL":"https:\/\/doi.org\/10.1007\/s00223-022-01039-y","relation":{},"ISSN":["1432-0827"],"issn-type":[{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,8]]},"assertion":[{"value":"29 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Jose A. Riancho have no conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}